Clinical trial
Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs
NCT00487604 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs
- Lead sponsor
- Providence Health & Services
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 31, 2007
- Completion date
- May 31, 2008
- Enrollment
- 9,800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.